Phaseline

Targets › SCN

SCN: drug programs, companies and trials

2 programs from 2 companies in 2 trials: 1 Phase 4, 1 Phase 2; Other.

Open in Phaseline: the race on SCN, likelihood bands and readouts

Programs

CompanyDrugTargetsHighest phaseConditionsNext expected readout
National University Hospital, SingaporePrilocaine
Sodium channel blocker (local anesthetic)
SCNPhase 4Knee Replacement, Total–
University of British ColumbiaST-01
Sustained release lidocaine (70 mg/mL); local anesthetic inhibiting sodium channels
SCNPhase 2Postoperative Pain–

Conditions

Knee Replacement, Total (1) Postoperative Pain (1)

Modalities

small molecule (2)

Companies

National University Hospital, Singapore (1) University of British Columbia (1)

Related targets

–

Programs group each company's trials by drug; targets and mechanisms come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood is in the app.